Investment Management of Virginia’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$2.47M Buy
2022
Q2
$2.5M Sell
2022
Q1
$4.19M Sell
2021
Q4
$6.91M Sell
2021
Q3
$6.29M Buy
2021
Q2
$5.46M Sell
2021
Q1
$6.71M Buy
2020
Q4
$3.34M Buy
2020
Q3
$1.75M Buy